Issue 1/2004
Content (9 Articles)
Synergistic Anti-Cancer Effects of Grape Seed Extract and Conventional Cytotoxic Agent Doxorubicin Against Human Breast Carcinoma Cells
Girish Sharma, Anil K. Tyagi, Rana P. Singh, Daniel C.F. Chan, Rajesh Agarwal
Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer
G.G. Van den Eynden, I. Van der Auwera, S. Van Laere, C.G. Colpaert, P. van Dam, S. Merajver, C.G. Kleer, A.L. Harris, E.A. Van Marck, L.Y. Dirix, P.B. Vermeulen
A Comparison of the Biological and Clinical Features of Invasive Lobular and Ductal Carcinomas of the Breast
T. Korhonen, H. Huhtala, K. Holli
Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure
Baoqing Guo, David J. Villeneuve, Stacey L. Hembruff, Angie F. Kirwan, David E. Blais, Michel Bonin, Amadeo M. Parissenti
Sequential Versus Combined Treatment of Human Breast Cancer Cells with Antiestrogens and the Vitamin D Analogue EB1089 and Evaluation of Predictive Markers for Vitamin D Treatment
G.L. Christensen, J.S. Jepsen, C.K. Fog, I.J. Christensen, A.E. Lykkesfeldt
Selective Cytotoxicity of a Red Grape Wine Flavonoid Fraction Against MCF-7 Cells
Fatima Hakimuddin, Gopinadhan Paliyath, Kelly Meckling
Are Medullary Breast Cancers an Indication for BRCA1 Mutation Screening? A Mutation Analysis of 42 Cases of Medullary Breast Cancer
P.T.C. Iau, M. Marafie, A. Ali, J.H. Sng, R.D. Macmillan, S. Pinder, H.E. Denley, I.O. Ellis, P. Wenzyck, N. Scott, G. Cross, R.W. Blamey
Association of Tamoxifen (TAM) and TAM Metabolite Concentrations with Self-Reported Side Effects of TAM in Women with Breast Cancer
Lisa Gallicchio, Gwyn Lord, Katherine Tkaczuk, Malcolm Danton, Lynn M. Lewis, Chang K. Lim, Jodi A. Flaws